Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2Classical hematology 2Myeloid 1Lymphoid 1

Conditions

Leukemia 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Lymphoma 22Leukemia, Myeloid, Acute 22Myelodysplastic Syndromes 21Breast Neoplasms 18Lymphoma, Non-Hodgkin 16Central Nervous System Neoplasms 14Burkitt Lymphoma 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Leukemia, Lymphocytic, Chronic, B-Cell 11Multiple Myeloma 10Leukemia, Myeloid, Accelerated Phase 10Hodgkin Disease 10Dendritic Cell Sarcoma, Interdigitating 10Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 9Leukemia, Myeloid, Chronic-Phase 9Leukemia, Biphenotypic, Acute 9Brain Neoplasms 9Blast Crisis 9Neuroblastoma 8Medulloblastoma 8Lymphoma, Mantle-Cell 8Recurrence 7Lymphoma, B-Cell, Marginal Zone 7Hematologic Neoplasms 7Ovarian Neoplasms 6Congenital Abnormalities 6

Interventions

fludarabine phosphate 3fludarabine 2Whole-Body Irradiation 2Thiotepa 2Melphalan 2Cyclosporins 2Cyclosporine 2Antilymphocyte Serum 2Alemtuzumab 2plerixafor 1Voriconazole 1Tacrolimus 1Photopheresis 1Phlebotomy 1Mycophenolic Acid 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cyclophosphamide 1Clofarabine 1Busulfan 1Blood Specimen Collection 1B-Cell Activating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Immunologic Deficiency Syndromes × Thiotepa × Clear all
NCT03609840 2023-09-21

Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡